Bernard John Clerkin net worth and biography

Bernard Clerkin Biography and Net Worth

CFO of Icon

Mr. Nigel Clerkin joined ICON as Chief Financial Officer in October 2024. Throughout his career, Mr. Clerkin has held numerous financial leadership positions, including Group CFO of Elan Corporation, CFO of ConvaTec, a global medical and technologies company, and CFO of UDG Healthcare. Immediately prior to joining ICON, he was CFO of LetsGetChecked, a global provider of at-home healthcare services. He commenced his career with KPMG. In addition to his extensive experience in the life sciences and healthcare services industries, Mr. Clerkin’s areas of expertise include M&A, financial processes and systems enhancement. Mr. Clerkin holds a Bachelor of Science (Accounting) degree and a Master of Accounting degree from Queen’s University Belfast. He is also a qualified chartered accountant and a fellow of Chartered Accountants Ireland.

What is Bernard John Clerkin's net worth?: The estimated net worth of Bernard John Clerkin is at least $992.48 thousand as of August 11th, 2026. Clerkin owns 5,881 shares of Icon stock worth more than $992,478 as of August 17th. This net worth evaluation does not reflect any other investments that Clerkin may own. Learn More about Bernard John Clerkin's net worth.
How do I contact Bernard John Clerkin?: The corporate mailing address for Clerkin and other Icon executives is SOUTH COUNTY BUSINESS PARK LEOPARDSTOWN, DUBLIN L2, 00000. Icon can also be reached via phone at (531) 291-2000. Learn More on Bernard John Clerkin's contact information.
Has Bernard John Clerkin been buying or selling shares of Icon?: During the last ninety days, Bernard John Clerkin has sold $372,445.43 of Icon stock. Most recently, Nigel Bernard John Clerkin sold 2,267 shares of the business's stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $164.29, for a transaction totalling $372,445.43. Following the completion of the sale, the chief financial officer now directly owns 5,881 shares of the company's stock, valued at $966,189.49. Learn More on Bernard John Clerkin's trading history.
Who are Icon's active insiders?: Icon's insider roster includes Barry Balfe (CEO), Brennan Brendan (CFO), Bernard Clerkin (CFO), John Climax (Director), Linda Grais (Director), Eugene Mccague (Director), Ronan Murphy (Director), Ciaran Murray (Director), and Anne Whitaker (Director). Learn More on Icon's active insiders.
Are insiders buying or selling shares of Icon?: In the last year, insiders at the medical research company sold shares 8 times. They sold a total of 9,531 shares worth more than $1,565,763.95. The most recent insider tranaction occured on August, 11th when Director Linda Grais sold 841 shares worth more than $138,167.89. Insiders at Icon own 44.0% of the company. Learn More about insider trades at Icon.
Information on this page was last updated on 8/11/2026.

Bernard John Clerkin Insider Trading History at Icon

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/11/2026	Sell	2,267	$164.29	$372,445.43	5,881

Bernard John Clerkin Buying and Selling Activity at Icon

Icon Company Overview

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Today's Range

Now: $169.45

$161.16

$169.73

50 Day Range

MA: $162.50

$140.73

$180.24

2 Week Range

Now: $169.45

$66.57

$203.91

Volume

485,724 shs

Average Volume

1,365,400 shs

Market Capitalization

$12.97 billion

P/E Ratio

39.78

Dividend Yield

N/A

Beta

1.21